Therefore, the aim of this study was to investigate whether the favorable characteristics of digital PET (dPET) compared to previous generation analog systems (aPET) could translate into improved disease localization in hormone-sensitive prostate cancer (PCa) patients with early biochemical recurrence/persistence (BCR/BCP) after radical treatment. The gene discussed is BCR; the disease is posterior cortical atrophy.